KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001366244-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 25, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
56,534
Total Value
$156,197.27
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 21, 2026 | Exercise/Conversion | 23,250 | โ | โ | 452,917 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 23, 2026 | Sale | 10,034 | $15.57 | $156,197.27 | 442,883 | Direct | โ | View Details | |
Director | Restricted Stock Unit | Derivative | Feb 21, 2026 | Exercise/Conversion | 23,250 | $0.00 | $0.00 | 279,000 | Direct | โ | View Details |